Microcarrier Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030

  • Single User License $3500

Microcarrier Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2030

Status : May, 2021 | Biotechnology

Report Digest


Global Microcarrier Market: Overview

The transition from stainless-steel bioreactors to single-use bioreactors, as well as increased investment on research and development activities by  biotechnology and pharmaceutical companies, are likely to drive growth of the global microcarrier market in the years to come. Rising demand for cell-based therapeutics and vaccines, the accelerated growth of the biologics and biosimilar sector, and increased research and development activities and financing for cell therapy research are all likely to benefit the global microcarrier market.

Many of the new biologics in the process of development are for indications that are dominated by small molecules and have a broad patient population. This means that biologics could make inroads into a number of non-traditional biologic disease areas in the near future and it could benefit from improved therapeutic efficacy. In addition to that, this creates room for the biosimilar industry to expand.

The “global microcarrier market” research makes an inclusion of main market segments such as equipment, consumables, microcarrier, application, end user, and regional markets. It also comprises a look at the current attractiveness of the global microcarrier market over the forecast timeframe of 2020 to 2030.

Global Microcarrier Market: Key Trends

Microcarriers assist in the development of cost-effective cells by minimizing both variable and fixed costs in large-scale production. The current situation has changed as a result of technological developments, and the importance of microcarriers in cell therapy has risen. Dissolvable microcarriers, for example, are presently available in the market and are made up of cross-linked polysaccharide polymers, which can be easily dissolved at the time of cell harvesting process. There is no need for separation since the microcarriers are fully dissolved, and the downstream process runs smoothly. As a result, these microcarriers are thought to be useful beads for large-scale cell therapy or cell production.

Cell culture is becoming a more important aspect of vaccine development in the pharmaceutical industry. Previously, vaccines were produced by cultivating and extracting viruses in chicken eggs, which was a lengthy process. Due to its  ability to manufacture vaccines in greater quantities as required and shorter lead time, cell-based vaccine development has emerged as a much more efficient approach in this regard. Clinical studies have shown that cell-based vaccines are as reliable, healthy, and efficacious as egg-based vaccines, in addition to these advantages. These benefits are likely to foster growth of the global microcarrier market over the analysis timeline.

Global Microcarrier Market: Competitive Assessment

A number of companies are prioritizing various stages of organic development, such as brand releases, patents,product approvals, and research and development activities. Acquisitions, alliances, and agreements are all considered inorganic growth strategies in this sector.

Some of the well-known players in the global microcarrier market are listed below:

  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc
  • Reaction Biology Corporation
  • Danaher Corporation
  • Charles River Laboratories
  • PerkinElmer, Inc.

Global Microcarrier Market: Regional Assessment

The global microcarrier market is likely to be led by the North America. This is primarily due to the region's growing gene and cell therapy research, as well as the programs that support it. The American Society of Gene and Cell Therapy, for example, is responsible for financing research and is also pushing biotech and biopharmaceutical firms to develop their R&D activities.

Furthermore, one of the major factors likely to drive the microcarrier market in North America region is the rapid and high growth of the biologics and biosimilars industry in the US.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?